Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Ka Hoʻokele ʻana i nā Pilikia Lōʻihi o ka CAR-T Therapy: Nā ʻIke mai ke Kanesa Kūlohelohe

2024-12-25

Ua hoʻololi ka lāʻau lapaʻau cell Chimeric Antigen Receptor (CAR)-T i ka mālama ʻana i nā maʻi hematologic, e hāʻawi ana i ka manaʻolana i nā poʻe maʻi me nā maʻi paʻakikī ʻē aʻe. Eia nō naʻe, ʻo nā pilikia lōʻihi e like me nā maʻi a me nā maʻi ʻino lua e mau ana i kahi hopohopo palekana koʻikoʻi, e like me kahi ʻatikala hou ma Ka maʻi ʻaʻai kūlohelohe.

 

Ua hoʻohana nui ʻia ka lāʻau lapaʻau CAR-T ma muli o kona hopena kupaianaha i nā hoʻokolohua lapaʻau a me nā noi maoli. ʻOiai ua lilo nā ʻawaʻawa koʻikoʻi e like me ka cytokine release syndrome (CRS) a me ka immune effector cell-associated neurotoxicity syndrome (ICANS) i mea hiki ke hoʻokele ʻia me nā holomua i ka mālama kākoʻo, ke hōʻike nei nā loiloi hou i ka nui o ka make ʻole o ka relapse (NRM) ma muli o nā maʻi a me nā maʻi ʻino lua i waena o nā mea pane CAR-T.

 

He meta-analysis e pili ana i ka 7,604 lymphoma a me ʻO ka Myeloma lehulehu Ua hōʻike nā mea maʻi i loaʻa i ka lāʻau lapaʻau CAR-T i kahi helu NRM holoʻokoʻa o 6.8%, e loli ana ma waena o nā maʻi like ʻole a me nā mea i kūkulu ʻia e CAR-T.ʻO nā maʻi i helu ʻia no ka hapa nui o nā hihia NRM, pili ʻole i ka Huahana CAR-T ʻo ia iho a i ʻole ka maʻi kumu. ʻOiai ka hopena koʻikoʻi o COVID-19 i ka wā o ke aʻo ʻana, ua hāʻawi nā maʻi bacteria a me nā fungal i 20% o nā make e pili ana i ka maʻi. Ua like kēia mau helu me nā mea i ʻike ʻia ma hope o ka hoʻoili ʻana o nā cell stem hematopoietic autologous (auto-HSCT).

 

No ka hōʻemi ʻana i kēia mau pilikia, hoʻoikaika nā mea noiʻi i ka pono o nā mea hana wānana e like me ka helu CAR-HEMATOTOX, kahi e loiloi ai i nā mea e like me ka mālama hematopoietic a me ka mumū baseline. Kōkua kēia ʻōnaehana helu i ka ʻike ʻana i nā maʻi kiʻekiʻe e pōmaikaʻi paha mai nā antibiotics prophylactic i hana kūikawā ʻia a me ka nānā ʻana i ka pale ʻana. ʻO ka mea nui, ua pili ka hematotoxicity cell effector cell-associated hematotoxicity (ICAHT) me kahi helu NRM kiʻekiʻe (14% versus 4.5% i nā hihia ʻaʻole koʻikoʻi).

 

ʻO nā maʻi malignancies lua, e like me nā myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), a me nā carcinomas, he mau pilikia koʻikoʻi ʻē aʻe. Ua pili nui kēia mau maʻi ʻino i nā lāʻau lapaʻau koʻikoʻi mua e like me ka chemotherapy a me ka auto-HSCT ma mua o ka huahana CAR-T ponoʻī. Ua ʻike ʻia ka hematopoiesis clonal, kahi mea mua i ka MDS/AML e pili ana i ka lāʻau lapaʻau, a hiki i ka 56% o nā maʻi ma mua o ka hoʻokomo ʻana o CAR-T.

 

Ke noiʻi ʻia nei ke kuleana o ka lāʻau lapaʻau CAR-T i loko o kēia mau maʻi ʻino. ʻOiai nā hihia o CAR-T-induced Lymphoma T-Cell ua hōʻike ʻia, ʻaʻole maopopo ka pilina kumu. I hoʻokahi hihia koʻikoʻi, ua ʻike ʻia nā pae CAR-RNA kiʻekiʻe i loko o kahi lymphoma T-cell gastrointestinal post-CAR-T therapy, akā naʻe ua kāpae nā loiloi genetic i ka hoʻokomo ʻana o CAR ma ke ʻano he kumu nui o ka malignancy.

 

Nā Hoʻolālā no ka Hoʻokele ʻana i nā Pōpilikia
No ka hoʻonui ʻana i ka ʻikepili pōmaikaʻi-pilikia o ka lāʻau lapaʻau CAR-T, paipai nā kānaka noiʻi i ke komo mua ʻana i nā poʻe maʻi me nā laina liʻiliʻi o ka lāʻau lapaʻau mua e hōʻemi i ka ʻona cumulative. Hiki i nā ʻōnaehana helu wānana a me ka hahai lōʻihi ʻana o nā mea loaʻa CAR-T ke hoʻonui hou i ka palekana ma o ka hiki ʻana ke ʻike mua a me ka hoʻokele ʻana i nā pilikia.

 

Hōʻike ka ʻatikala i ke koʻikoʻi o ka hōʻike ʻana i nā hanana ʻino piha i nā hoʻokolohua lapaʻau a me nā papa inoa, ʻoi aku hoʻi no nā maʻi, nā maʻi ʻino lua, a me NRM. E kōkua kēlā ʻikepili i nā kauka lapaʻau e hoʻomaʻamaʻa i nā protocol lapaʻau a me nā pae koho koho maʻi.

 

Hopena
ʻOiai ke hōʻike nei ka lāʻau lapaʻau CAR-T i ka hiki ke hoʻōla ʻia no nā maʻi hematologic, he mea nui ka hoʻokele ʻana i kona mau pilikia lōʻihi. Pono ka noiʻi e hiki mai ana e kālele i ka hoʻomaʻemaʻe ʻana i nā mea hana wānana a me ka ʻimi ʻana i nā lāʻau lapaʻau ʻē aʻe no nā poʻe maʻi ʻelemakule a nāwaliwali paha i ʻole e ʻae maikaʻi i nā mea ʻawaʻawa e pili ana iā CAR-T.

He mea hoʻomanaʻo kēia hana hou i ka pono e hoʻokaulike i ka pono a me ka palekana i nā lāʻau lapaʻau hou, e hōʻoia ana i nā hopena maikaʻi loa no nā maʻi ma ka honua holoʻokoʻa.